146 related articles for article (PubMed ID: 28579395)
1. Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo.
Wakeman DR; Hiller BM; Marmion DJ; McMahon CW; Corbett GT; Mangan KP; Ma J; Little LE; Xie Z; Perez-Rosello T; Guzman JN; Surmeier DJ; Kordower JH
Stem Cell Reports; 2017 Jul; 9(1):149-161. PubMed ID: 28579395
[TBL] [Abstract][Full Text] [Related]
2. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.
Sundberg M; Bogetofte H; Lawson T; Jansson J; Smith G; Astradsson A; Moore M; Osborn T; Cooper O; Spealman R; Hallett P; Isacson O
Stem Cells; 2013 Aug; 31(8):1548-62. PubMed ID: 23666606
[TBL] [Abstract][Full Text] [Related]
3. Survival and maturation of human induced pluripotent stem cell-derived dopaminergic progenitors in the parkinsonian rat brain is enhanced by transplantation in a neurotrophin-enriched hydrogel.
Comini G; Kelly R; Jarrin S; Patton T; Narasimhan K; Pandit A; Drummond N; Kunath T; Dowd E
J Neural Eng; 2024 Mar; 21(2):. PubMed ID: 38479026
[No Abstract] [Full Text] [Related]
4. TREM2 gene induces differentiation of induced pluripotent stem cells into dopaminergic neurons and promotes neuronal repair via TGF-β activation in 6-OHDA-lesioned mouse model of Parkinson's disease.
Liang H; Liu P; Wang Z; Xiong H; Yin C; Zhao D; Wu C; Chen L
CNS Neurosci Ther; 2024 Feb; 30(2):e14630. PubMed ID: 38348765
[TBL] [Abstract][Full Text] [Related]
5. Peptide-Based Scaffolds for the Culture and Transplantation of Human Dopaminergic Neurons.
Francis NL; Zhao N; Calvelli HR; Saini A; Gifford JJ; Wagner GC; Cohen RI; Pang ZP; Moghe PV
Tissue Eng Part A; 2020 Feb; 26(3-4):193-205. PubMed ID: 31537172
[TBL] [Abstract][Full Text] [Related]
6. Single-Cell Sequencing of iPSC-Dopamine Neurons Reconstructs Disease Progression and Identifies HDAC4 as a Regulator of Parkinson Cell Phenotypes.
Lang C; Campbell KR; Ryan BJ; Carling P; Attar M; Vowles J; Perestenko OV; Bowden R; Baig F; Kasten M; Hu MT; Cowley SA; Webber C; Wade-Martins R
Cell Stem Cell; 2019 Jan; 24(1):93-106.e6. PubMed ID: 30503143
[TBL] [Abstract][Full Text] [Related]
7. Development of Midbrain Dopaminergic Neurons and the Advantage of Using hiPSCs as a Model System to Study Parkinson's Disease.
Samson JS; Ramesh A; Parvathi VD
Neuroscience; 2024 May; 546():1-19. PubMed ID: 38522661
[TBL] [Abstract][Full Text] [Related]
8. Human Clinical-Grade Parthenogenetic ESC-Derived Dopaminergic Neurons Recover Locomotive Defects of Nonhuman Primate Models of Parkinson's Disease.
Wang YK; Zhu WW; Wu MH; Wu YH; Liu ZX; Liang LM; Sheng C; Hao J; Wang L; Li W; Zhou Q; Hu BY
Stem Cell Reports; 2018 Jul; 11(1):171-182. PubMed ID: 29910127
[TBL] [Abstract][Full Text] [Related]
9. Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease.
Park S; Park CW; Eom JH; Jo MY; Hur HJ; Choi SK; Lee JS; Nam ST; Jo KS; Oh YW; Lee J; Kim S; Kim DH; Park CY; Kim SJ; Lee HY; Cho MS; Kim DS; Kim DW
Cell Stem Cell; 2024 Jan; 31(1):25-38.e8. PubMed ID: 38086390
[TBL] [Abstract][Full Text] [Related]
10. Human iPSC-based modeling of late-onset disease via progerin-induced aging.
Miller JD; Ganat YM; Kishinevsky S; Bowman RL; Liu B; Tu EY; Mandal PK; Vera E; Shim JW; Kriks S; Taldone T; Fusaki N; Tomishima MJ; Krainc D; Milner TA; Rossi DJ; Studer L
Cell Stem Cell; 2013 Dec; 13(6):691-705. PubMed ID: 24315443
[TBL] [Abstract][Full Text] [Related]
11. Combining physical & cognitive training with iPSC-derived dopaminergic neuron transplantation promotes graft integration & better functional outcome in parkinsonian marmosets.
Daadi EW; Daadi ES; Oh T; Li M; Kim J; Daadi MM
Exp Neurol; 2024 Apr; 374():114694. PubMed ID: 38272159
[TBL] [Abstract][Full Text] [Related]
12. Autologous iPSC-derived dopamine neuron transplantation in a nonhuman primate Parkinson's disease model.
Wang S; Zou C; Fu L; Wang B; An J; Song G; Wu J; Tang X; Li M; Zhang J; Yue F; Zheng C; Chan P; Zhang YA; Chen Z
Cell Discov; 2015; 1():15012. PubMed ID: 27462412
[TBL] [Abstract][Full Text] [Related]
13. Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson's iPSC-dopamine neurons.
Beccano-Kelly DA; Cherubini M; Mousba Y; Cramb KML; Giussani S; Caiazza MC; Rai P; Vingill S; Bengoa-Vergniory N; Ng B; Corda G; Banerjee A; Vowles J; Cowley S; Wade-Martins R
iScience; 2023 Jul; 26(7):107044. PubMed ID: 37426342
[TBL] [Abstract][Full Text] [Related]
14. TNF-NFkB-p53 axis restricts
Kim TW; Koo SY; Riessland M; Cho H; Chaudhry F; Kolisnyk B; Russo MV; Saurat N; Mehta S; Garippa R; Betel D; Studer L
bioRxiv; 2023 Mar; ():. PubMed ID: 37034664
[TBL] [Abstract][Full Text] [Related]
15. TNF-NF-κB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons.
Kim TW; Koo SY; Riessland M; Chaudhry F; Kolisnyk B; Cho HS; Russo MV; Saurat N; Mehta S; Garippa R; Betel D; Studer L
Cell; 2024 Jun; ():. PubMed ID: 38866017
[TBL] [Abstract][Full Text] [Related]
16. Cell line specific alterations in genes associated with dopamine metabolism and signaling in midbrain dopaminergic neurons derived from 22q11.2 deletion carriers with elevated dopamine synthesis capacity.
Reid MJ; Rogdaki M; Dutan L; Hanger B; Sabad K; Nagy R; Adhya D; Baron-Cohen S; McAlonan G; Price J; Vernon AC; Howes OD; Srivastava DP
Schizophr Res; 2022 Jun; ():. PubMed ID: 35701280
[TBL] [Abstract][Full Text] [Related]
17. Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutations.
Singh Dolt K; Hammachi F; Kunath T
Brain Pathol; 2017 Jul; 27(4):545-551. PubMed ID: 28585381
[TBL] [Abstract][Full Text] [Related]
18. Creation of a library of induced pluripotent stem cells from Parkinsonian patients.
Holmqvist S; Lehtonen Š; Chumarina M; Puttonen KA; Azevedo C; Lebedeva O; Ruponen M; Oksanen M; Djelloul M; Collin A; Goldwurm S; Meyer M; Lagarkova M; Kiselev S; Koistinaho J; Roybon L
NPJ Parkinsons Dis; 2016; 2():16009. PubMed ID: 28725696
[TBL] [Abstract][Full Text] [Related]
19. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.
Kikuchi T; Morizane A; Doi D; Magotani H; Onoe H; Hayashi T; Mizuma H; Takara S; Takahashi R; Inoue H; Morita S; Yamamoto M; Okita K; Nakagawa M; Parmar M; Takahashi J
Nature; 2017 Aug; 548(7669):592-596. PubMed ID: 28858313
[TBL] [Abstract][Full Text] [Related]
20. Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Adult Common Marmoset Fibroblasts.
Vermilyea SC; Guthrie S; Meyer M; Smuga-Otto K; Braun K; Howden S; Thomson JA; Zhang SC; Emborg ME; Golos TG
Stem Cells Dev; 2017 Sep; 26(17):1225-1235. PubMed ID: 28635509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]